Migräne verstehen: von der klinischen Untersuchung zu
                    standardisierten Behandlungsstrategien

Juliana Pradela; Robert-Christopher Eschke; Débora Bevilaqua-Grossi; Kerstin Lüdtke

doi:10.1055/a-2344-7948

MSK – Muskuloskelettale Physiotherapie, Table of Contents

MSK – Muskuloskelettale Physiotherapie 2024; 28(04): 231-240
DOI: 10.1055/a-2344-7948

Schmerzseiten

Migräne verstehen: von der klinischen Untersuchung zu standardisierten Behandlungsstrategien

Juliana Pradela

,

Robert-Christopher Eschke

,

Débora Bevilaqua-Grossi

,

Kerstin Lüdtke

Abstract

Physiotherapie spielt eine wichtige Rolle beim Management der Migräne, da eine Kombination aus medikamentöser und nicht-medikamentöser Therapie am wirksamsten ist. Um eine bestmögliche Therapie anzubieten, ist es essenziell, anhand von Assessments zu verstehen, wie und in welchen Bereichen die Migräne das Leben der Patient*innen am meisten beeinflusst. Dieser Artikel gibt einen narrativen Überblick über die aktuelle Literatur zur Migräne mit Schwerpunkt auf Diagnostik, klinischer Untersuchung, assoziierten Komorbiditäten und standardisierten Beurteilungs- und Behandlungsstrategien.

Full Text

References

Literatur
1 GBD 2016 Headache Collaborators. Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2018; 17: 954-976
2 Steiner TJ, Stovner LJ, Vos T. Migraine is the first cause of disability in under 50 s: will health politicians now take notice?. J Headache Pain 2018; 19: 104
3 World Health Organization. Migraine and other headache disorders. (6 March 2024). Im Internet: https://bit.ly/3LQ1Il6; Stand: 01.08.2024
4 GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017; 390: 1211-1259
5 Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3^rdedition (ICHD-III). Cephalalgia 2018; 38: 1-211
6 Lipton RB, Bigal ME, Diamond M. et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007; 68: 343-349
7 Russell MB, Olesen J. A nosographic analysis of the migraine aura in a general population. Brain 1996; 119: 355-361
8 Thomsen AV, Ashina H, Al-Khazali HM. Clinical features of migraine with aura: a REFORM study. J Headache Pain 2024; 25: 22
9 Charles A. The evolution of a migraine attack – a review of the evidence. Headache 2013; 53: 413-419
10 Goadsby PJ, Holland PR, Martins-Oliveira M. et al. Pathophysiology of migraine: A disorder of sensory processing. Physiol Rev 2017; 97: 553-622
11 Giffin NJ, Ruggiero L, Lipton RB. et al. Premonitory symptoms in migraine: An electronic diary study. Neurology 2003; 60: 935-940
12 Kelman L. The postdrome of the acute migraine attack. Cephalalgia 2006; 26: 214-220
13 Carvalho IV, Fernandes CS, Damas DP. et al. The migraine postdrome: Clinical characterization, influence of abortive treatment and impact in the quality of life. Clin Neurol Neurosurg 2022; 221: 107408
14 Pietrobon D, Moskowitz MA. Pathophysiology of migraine. Annu Rev Physiol 2013; 75: 365-391
15 Goadsby PJ, Holland PR, Martins-Oliveira M. et al. Pathophysiology of migraine: A disorder of sensory processing. Physiol Rev 2017; 97: 553-622
16 Schulte LH, May A. Of generators, networks and migraine attacks. Curr Opin Neurol 2017; 30: 241-245
17 Bartsch T, Goadsby PJ. The trigeminocervical complex and migraine: Current concepts and synthesis. Curr Pain Headache Rep 2003; 7: 371-376
18 Dodick DW, Silberstein SD. Central sensitization theory of migraine: clinical implications. Headache 2006; 46: S182-S191
19 Florencio LL, de Oliveira IV, Lodovichi SS. et al. Cervical muscular endurance performance in women with and without migraine. J.Orthop Sports Phys Ther 2019; 49: 330-336
20 Bevilaqua-Grossi D, Pinheiro-Araujo CF, Carvalho GF. et al. Neck pain repercussions in migraine - The role of physiotherapy. Musculoskelet Sci Pract 2023; 66: 102786
21 Radat F. What is the link between migraine and psychiatric disorders? From epidemiology to therapeutics. Rev Neurol (Paris) 2021; 177: 821-826
22 Calhoun AH, Ford S, Pruitt AP. et al. The point prevalence of dizziness or vertigo in migraine and factors that influence presentation. Headache 2011; 51: 1388-1392
23 Carvalho GF, Vianna-Bell FH, Florencio LL. et al. Presence of vestibular symptoms and related disability in migraine with and without aura and chronic migraine. Cephalalgia 2019; 39: 29-37
24 Carvalho GF, Luedtke K, Bevilaqua-Grossi D. Balance Disorders and migraine. Musculoskeletal Sci Pract 2023; 66: 102783
25 Carvalho GF, Schwarz A, Szikszay TM. et al. Physical therapy and migraine: musculoskeletal and balance dysfunctions and their relevance for clinical practice. Braz J Phys Ther 2020; 24: 306-317
26 Ashina S, Bendtsen L, Lyngberg AC. et al. Prevalence of neck pain in migraine and tension-type headache: A population study. Cephalalgia 2015; 35: 211-219
27 Florencio LL, Chaves TC, Carvalho GF, Gonçalves MC, Casimiro EC, Dach F, Bigal ME, Bevilaqua-Grossi D. Neck pain disability is related to the frequency of migraine attacks: a cross-sectional study. Headache. 2014; Jul-Aug 54: 1203-1210 Epub 2014 May 26
28 Luedtke K, Starke W, May A. Musculoskeletal dysfunction in migraine patients. Cephalalgia 2018; 38: 865-875
29 Watson DH, Drummond PD. Head pain referral during examination of the neck in migraine and tension-type. headache. Headache 2012; 52: 1226-1235
30 Florencio LL, de Oliveira AS, Carvalho GF. et al. Cervical muscle strength and muscle co-activation during isometric contractions in patients with migraine: a cross-sectional study. Headache 2015; 55: 1312-1322
31 Tolentino GA, Bevilaqua-Grossi D, Carvalho GF. et al. Relationship between headaches and neck pain characteristics with neck muscle strength. J Manipulative Physiol Ther 2018; 41: 650-657
32 Kurth T, Schürks M, Logroscino G. et al. Migraine, vascular risk, and cardiovascular events in women: prospective cohort study. BMJ 2008; 337: a636
33 Lee MJ, Lee C, Chung C-S. The migraine–stroke connection. J Stroke 2016; 18: 146-156
34 Alqaqa A. The Association of Cardiovascular Disease and Migraine: Review. J Clini Exp Cardiol 2016; 7: 465
35 Saeed A, Rana KF, Warriach ZI. et al. Association of migraine and ischemic heart disease: a review. Cureus 2019; 11: e5719
36 Smitherman TA, Maizels M, Penzien DB. Headache chronification: Screening and behavioral management of comorbid depressive and anxiety disorders. Headache 2008; 48: 45-50
37 Buse DC, Silberstein SD, Manack AN. et al. Psychiatric comorbidities of episodic and chronic migraine. J Neurol 2013; 260: 1960-1969
38 Lipton RB, Hamelsky SW, Kolodner KB. et al. Migraine, quality of life, and depression: a population-based case-control study. Neurology 2000; 55: 629-635
39 Breslau N, Davis GC, Andreski P. Migraine, psychiatric disorders, and suicide attempts: an epidemiologic study of young adults. Psychiatry Res 1991; 37: 11-23
40 Benatto MT, Bevilaqua-Grossi D, Carvalho GF. et al. Kinesiophobia Is Associated with Migraine. Pain Med 2019; 20: 846-851
41 Aamodt AH, Stovner LJ, Hagen K. et al. Comorbidity of headache and gastrointestinal complaints. The Head-HUNT Study. Cephalalgia 2008; 28: 144-151
42 Arzani M, Jahromi SR, Ghorbani Z. et al. Gut-brain axis and migraine headache: a comprehensive review. J Headache Pain 2020; 21: 15
43 McGill AT. Causes of metabolic syndrome and obesity-related co-morbidities. Part 1: a composite unifying theory review of human-specific co-adaptations to brain energy consumption. Arch Public Health 2014; 72: 30
44 McCarthy LH, Bigal ME, Katz M. et al. Chronic pain and obesity in elderly people: results from the Einstein aging study. J Am Geriatr Soc 2009; 57: 15-19
45 Pavlovic JM, Vieira JR, Lipton RB. et al. Association Between Obesity and Migraine in Women. Curr Pain Headache Rep 2017; 21: 41
46 Ford ES, Li C, Pearson WS, Zhao G. et al. Body mass index and headaches: findings from a national sample of US adults. Cephalalgia 2008; 28: 1270-1276
47 Mattsson P. Migraine headache and obesity in women aged 40–74 years: a population-based study. Cephalalgia 2007; 27: 877-880
48 Keith SW, Wang C, Fontaine KR. et al. BMI and headache among women: results from 11 epidemiologic datasets. Obesity (Silver Spring) 2008; 16: 377-383
49 Bigal ME, Liberman JN, Lipton RB. Obesity and migraine: a population study. Neurology 2006; 66: 545-550
50 Bigal ME, Lipton RB. Putative mechanisms of the relationship between obesity and migraine progression. Curr Pain Headache Rep 2008; 12: 207-212
51 Cavestro C, Ferrero M. Migraine in Systemic Autoimmune Diseases. Endocr Metab Immune Disord Drug Targets 2018; 18: 124-134
52 Do TP, Remmers A, Schytz HW. et al. Red and orange flags for secondary headaches in clinical practice: SNNOOP10 list. Neurology 2019; 92: 134-144
53 Eigenbrodt AK, Ashina H, Khan S. et al. Diagnosis and management of migraine in ten steps. Nat Rev Neurol. 2021 17. 501-514
54 Luedtke K, Boissonnault W, Caspersen N. et al. International consensus on the most useful physical examination tests used by physiotherapists for patients with headache: A Delphi study. Man Ther 2016; 23: 17-24
55 Burch RC, Loder S, Loder E. et al. The prevalence and burden of migraine and severe headache in the United States: Updated statistics from government health surveillance studies. Headache 2015; 55: 21-34
56 Goadsby PJ, Holland PR, Martins-Oliveira M. et al. Pathophysiology of Migraine: A Disorder of Sensory Processing. Physiol Rev 2017; 97: 553-622
57 Silberstein SD, Tfelt-Hansen P, Dodick DW. et al. Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults. Cephalalgia 2008; 28: 484-495
58 Hoffmann J, Recober A. Migraine and triggers: post hoc ergo propter hoc?. Curr Pain Headache Rep 2013; 17: 370
59 Buse DC, Scher AI, Dodick DW. et al. Impact of migraine on the family: Perspectives of people with migraine and their spouse/domestic partner in the CaMEO study. Mayo Clin Prc 2016; 91: 596-611
60 Stokes M, Becker WJ, Lipton RB. et al. Cost of health care among patients with chronic and episodic migraine in Canada and the USA: Results from the International Burden of Migraine Study (IBMS). Headache 2011; 51: 1058-1077
61 Steiner TJ, Terwindt GM, Katsarava Z. et al. Migraine-attributed burden, impact and disability, and migraine-impacted quality of life: Expert consensus on definitions from a Delphi process. Cephalalgia 2022; 42: 1387-1396
62 Vincent M, Viktrup L, Nicholson RA. et al. The not so hidden impact of interictal burden in migraine: A narrative review. Front Neurol 2022; 13: 1032103
63 Leonardi M, Raggi A, Bussone G. et al. Health-related quality of life, disability and severity of disease in patients with migraine attending to a specialty headache center. Headache 2010; 50: 1576-1586
64 Mokkink LB, Terwee CB, Patrick DL. et al. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res 2010; 19: 539-549
65 Luedtke K, Basener A, Bedei S. et al. Outcome measures for assessing the effectiveness of non-pharmacological interventions in frequent episodic or chronic migraine: a Delphi study. BMJ Open 2020; 10: e029855
66 Minen MT, Begasse De Dhaem O, Kroon Van Diest A. et al. Migraine and its psychiatric comorbidities. J Neurol Neurosurg Psychiatry 2016; 87: 741-749
67 Louter MA, Pijpers JA, Wardenaar KJ. et al. Symptom dimensions of affective disorders in migraine patients. J Psychosom Res 2015; 79: 458-463
68 Spitzer RL, Kroenke K, Williams JB. et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006; 166: 1092-1097
69 Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001; 16: 606-613
70 Bagley CL, Rendas-Baum R, Maglinte GA. et al. Validating Migraine-Specific Quality of Life Questionnaire v2.1 in episodic and chronic migraine. Headache 2012; 52: 409-421
71 Holroyd KA, Malinoski P, Davis MK. et al. The three dimensions of headache impact: Pain, disability and affective distress. Pain 1999; 83: 571-578
72 Usai S, Grazzi L, D’Amico D. et al. Reduction in the impact of chronic migraine with medication overuse after day-hospital withdrawal therapy. Neurol Sci 2008; 29: 176-178
73 Stewart WF, Lipton RB, Dowson AJ. et al. Development and testing of the migraine disability assessment (MIDAS) questionnaire to assess headache-related disability. Neurology 2001; 56: S20-S28
74 Carvalho GF, Luedtke K, Braun T. Minimal important change and responsiveness of the Migraine Disability Assessment Score (MIDAS) questionnaire. J Headache Pain 2021; 22: 126
75 Kosinski M, Bayliss MS, Bjorner JB. et al. A six-item short-form survey for measuring headache impact: the HIT-6. Qual Life Res 2003; 12: 963-974
76 Pradela J, Bevilaqua-Grossi D, Chaves TC. et al. Measurement properties of the Headache Impact Test (HIT-6™ Brazil) in primary and secondary headaches. Headache 2021; 61: 527-535
77 Ashina M, Buse DC, Ashina H. et al. Migraine: integrated approaches to clinical management and emerging treatments. Lancet 2021; 397: 1505-1518
78 Haghdoost F, Puledda F, Garcia-Azorin D. et al. Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials. Cephalalgia 2023; 43: 3331024231159366
79 Herd CP, Tomlinson CL, Rick C. et al. Botulinum toxins for the prevention of migraine in adults. Cochrane Database Syst Rev 2018; 6: CD011616
80 Luedtke K, Allers A, Schulte LH. Efficacy of interventions used by physiotherapists for patients with headache and migraine-systematic review and meta-analysis. Cephalalgia 2016; 36: 474-492
81 Carvalho G, Quinn R, Luedtke K. Migraine patients' experiences with and expectations from physiotherapy. Musculoskelet Sci Pract 2023; 66: 102803
82 Luedtke K, Allers A, Schulte LH. et al. Efficacy of interventions used by physiotherapists for patients with headache and migraine-systematic review and meta-analysis. Cephalalgia 2016; 36: 474-492
83 Woldeamanuel YW, Oliveira ABD. What is the efficacy of aerobic exercise versus strength training in the treatment of migraine? A systematic review and network meta-analysis of clinical trials. J Headache Pain 2022; 23: 134
84 Bae JY, Sung HK, Kwon NY. et al. Cognitive Behavioral Therapy for Migraine Headache: A Systematic Review and Meta-Analysis. Medicina (Kaunas) 2021; 58: 44
85 Klan T, Gaul C, Liesering-Latta E. et al. Behavioral treatment for migraine prophylaxis in adults: Moderator analysis of a randomized controlled trial. Cephalalgia 2023; 43: 3331024231178237
86 Seng EK, Martin PR, Houle TT. Lifestyle factors and migraine. Lancet Neurol 2022; 21: 911-921
87 Kropp P, Meyer B, Meyer W. et al. An update on behavioral treatments in migraine - current knowledge and future options. Expert Rev Neurother 2017; 17: 1059-1068
88 Puledda F, Shields K. Non-Pharmacological Approaches for Migraine. Neurotherapeutics 2018; 15: 336-345